Quintiles & Biogen Idec begin strategic partnership

Quintiles and Biogen Idec have announced that they have entered into a five-year strategic clinical development agreement. The multi-year collaboration is designed to leverage the expertise and experience from both organizations to optimize Biogen Idec’s clinical development processes.

The collaboration is structured to increase clinical trial efficiency, with a focus on transparency, quality, innovation and operational excellence. Under the agreement, a dedicated team from Quintiles will work with Biogen Idec on the design, planning and execution of Biogen Idec’s phase II-IV studies and select phase I studies. In addition, Biogen Idec will leverage Quintiles’ technology and systems across its growing portfolio.

The collaboration is already underway. New projects are being initiated through the collaboration, and several of Biogen Idec’s ongoing studies are currently transitioning to Quintiles.